In Our Dreams: Improving the Health of Patients Living with IH and Narcolepsy by Connecting with Their Hearts and Heads
View the day’s summary video and access the abstracts below.
This program is supported by an independent medical education grant from Jazz Pharmaceuticals
Meet the Faculty:
Anne Marie Morse, DO
Director, Child Neurology
Director, Pediatric Sleep Medicine
Program Director, Child Neurology Residency
Geisinger Janet Weis Children’s Hospital
Associate Professor, Geisinger Commonwealth School of Medicine
School of Medicine
Danville, PA
Abstracts:
1. Vibrance-1: A Randomized Phase 2 Study Evaluating Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton (ALKS 2680) in Patients with Narcolepsy Type 1
2. Clinical Characterization of Patients with Abnormal Multiple Sleep Latency Test: A 10-Year Cohort Study
3. Effect of Narcolepsy and Idiopathic Hypersomnia on Relationships: A Social Media Analysis
4. Impact of Stigma Associated with Narcolepsy Type 1: Insights from a Global Qualitative Study
5. Demographics and Comorbidities of Patients With Narcolepsy: A Propensity Score–Matched Cohort Study
6. Risk of New-onset Cardiovascular and Cardiometabolic Conditions in Narcolepsy: An Analysis of the All of Us Research Program
7. Association Between Sodium Intake and Systolic and Diastolic Blood Pressure: A Systematic Literature Review and Meta-analysis